Osaic Holdings’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.4K | Buy |
1,914
+802
| +72% | +$20.3K | ﹤0.01% | 4718 |
|
|
2025
Q1 | $24.3K | Sell |
1,112
-233
| -17% | -$5.1K | ﹤0.01% | 5190 |
|
|
2024
Q4 | $36.8K | Sell |
1,345
-769
| -36% | -$21.1K | ﹤0.01% | 4894 |
|
|
2024
Q3 | $61K | Sell |
2,114
-158
| -7% | -$4.56K | ﹤0.01% | 4583 |
|
|
2024
Q2 | $87.2K | Sell |
2,272
-729
| -24% | -$28K | ﹤0.01% | 4238 |
|
|
2024
Q1 | $176K | Sell |
3,001
-2,990
| -50% | -$176K | ﹤0.01% | 3792 |
|
|
2023
Q4 | $359K | Sell |
5,991
-60
| -1% | -$3.59K | ﹤0.01% | 3438 |
|
|
2023
Q3 | $230K | Buy |
6,051
+1,082
| +22% | +$41.2K | ﹤0.01% | 3891 |
|
|
2023
Q2 | $452K | Sell |
4,969
-9,268
| -65% | -$844K | ﹤0.01% | 3233 |
|
|
2023
Q1 | $939K | Buy |
14,237
+10,988
| +338% | +$725K | ﹤0.01% | 2531 |
|
|
2022
Q4 | $167K | Buy |
3,249
+209
| +7% | +$10.7K | ﹤0.01% | 4014 |
|
|
2022
Q3 | $209K | Buy |
3,040
+373
| +14% | +$25.6K | ﹤0.01% | 3692 |
|
|
2022
Q2 | $120K | Buy |
2,667
+62
| +2% | +$2.79K | ﹤0.01% | 4259 |
|
|
2022
Q1 | $132K | Sell |
2,605
-741
| -22% | -$37.5K | ﹤0.01% | 4359 |
|
|
2021
Q4 | $158K | Sell |
3,346
-655
| -16% | -$30.9K | ﹤0.01% | 4170 |
|
|
2021
Q3 | $132K | Buy |
4,001
+1,788
| +81% | +$59K | ﹤0.01% | 4279 |
|
|
2021
Q2 | $139K | Buy |
2,213
+7
| +0.3% | +$440 | ﹤0.01% | 4195 |
|
|
2021
Q1 | $95K | Sell |
2,206
-90
| -4% | -$3.88K | ﹤0.01% | 4384 |
|
|
2020
Q4 | $131K | Sell |
2,296
-100
| -4% | -$5.71K | ﹤0.01% | 3835 |
|
|
2020
Q3 | $73K | Hold |
2,396
| – | – | ﹤0.01% | 4039 |
|
|
2020
Q2 | $78K | Sell |
2,396
-160
| -6% | -$5.21K | ﹤0.01% | 3859 |
|
|
2020
Q1 | $68K | Buy |
+2,556
| New | +$68K | ﹤0.01% | 3741 |
|